ArticleMolecular oncology2023

Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease.

Mohamed E Elsesy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.